Clinical trials in Gabon
76 studies list at least one site in Gabon. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-15.
Status
- Completed
- 52
- Status unknown
- 8
- Recruiting
- 7
- Terminated
- 7
- Not yet recruiting
- 2
Phase
- Phase 2
- 29
- Phase 1
- 12
- Phase 4
- 11
- Phase 3
- 9
Most studied here
Who runs them
Centre de Recherche Médicale de Lambaréné (13) · Novartis Pharmaceuticals (9) · Albert Schweitzer Hospital (9) · Sanofi (6) · GlaxoSmithKline (4) · Medicines for Malaria Venture (4) · Barcelona Institute for Global Health (3) · African Malaria Network Trust (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 76 — search for more.
- Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum InfectionNot yet recruitingNCT07819825Phase 1
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)RecruitingNCT07811908Phase 2
- A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)RecruitingNCT06422338Not applicable
- PanACEA - STEP2C -01RecruitingNCT05807399Phase 2
- Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking AfricaRecruitingNCT03803735
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRecruitingNCT05750628Phase 2
- A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum CarriersRecruitingNCT05911828Phase 1
- A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and ArtesunateNot yet recruitingNCT05929157Phase 1/2
- Seroepidemiological Investigation of Coronavirus 2019 (COVID-19) Infection in GabonRecruitingNCT05065632
- Controlled Human Malaria Infection by Mosquito Bites Using a Local Strain of Plasmodium FalciparumCompletedNCT07816497Phase 1
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)CompletedNCT07811882Phase 2
- Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT04546633Phase 2
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B2)CompletedNCT07235033Phase 2
- Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug ResistanceCompletedNCT03057756
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT07235020Phase 2
- Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)CompletedNCT05689047Phase 2
- Pan-Malaria Transmission-Blocking Vaccine AnAPN1CompletedNCT05905432Phase 1
- Monitoring COVID-19 Vaccination Response in Fragile PopulationsCompletedNCT05222139
- Evaluation of Efficacy and Safety of VPM1002 in Comparison to BCG in Prevention of Tb Infection in InfantsCompletedNCT04351685Phase 3
- Improving Maternal heAlth by Reducing Malaria in African HIV WomenCompletedNCT03671109Phase 3
- Prevalence and Impact of COVID-19 on Maternal and Infant Health in African PopulationsCompletedNCT05303168
- Evaluation of the VOT Among Tuberculosis Patients From LambarénéCompletedNCT05865626Not applicable
- Safety and Immunogenicity of the rVSVΔG-ZEBOV-GP Ebola Virus Vaccine Candidate in Children Living in Lambaréné, GabonCompletedNCT05130398Phase 1/2
- Important Data on COVID-19 Profile in AfricaCompletedNCT04847817
- Variants of SARS-CoV-2 Causing COVID-19 in AfricaStatus unknownNCT05311891
- Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum MalariaCompletedNCT00331136Phase 2
- To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedNCT02497612Phase 2
- Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT03660839Phase 2
- Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT03167242Phase 2
- Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric PatientsCompletedNCT00541385Phase 3
- Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.CompletedNCT03334747Phase 2
- Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese ChildrenCompletedNCT03521973Phase 2
- Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in GabonCompletedNCT04326868Phase 4
- Schistosomiasis Diagnosis Using a CAA Antigen TestStatus unknownNCT03779347Phase 3
- Validation of Promising Biomarker Assays to Assess Their Diagnostic Performance CharacteristicsCompletedNCT03047642
- Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese AdultsCompletedNCT03373214Phase 1
- Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, GabonCompletedNCT04205669Phase 4
- Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicityCompletedNCT02769013
- Epidemiology Study of Malaria Transmission Intensity in AfricaCompletedNCT01190202Not applicable
- Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.Status unknownNCT04505046
- Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infectionCompletedNCT04264130Phase 2
- Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in AfricaCompletedNCT00866619Phase 3
- Cohort Event Monitoring Study of Pyramax®CompletedNCT03201770Phase 4
- Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled TrialTerminatedNCT02342002Phase 4
- Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI RegimenCompletedNCT00436007Phase 2
- Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytoseStatus unknownNCT03114137
- A Survey of Hospitalizations in Cardiology Units in Sub-Saharan AfricaStatus unknownNCT03231449
- Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese AdultsCompletedNCT02126462Phase 1
- Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese ChildrenCompletedNCT00307021Phase 2